glp-1 psychiatry Medications in Psychiatry: Evidence-Based Guidance glp1 #psychiatry | Roa Gamal

By inhibiting alpha-glucosidase, alpha-glucosidase inhibitors slow the absorption of glucose from the gut, blunting the post-meal rise in blood glucose

Gastrointestinal effects remain the most common complaint

Advertisement And even though it may seem like everyone on social media is talking about microdosing GLP-1s, you shouldnt microdose your medication (or adjust your dosage) without consulting your healthcare provider first

Think about what that means in practical terms

The strongest risk factor for CVD and mortality in T2D is diabetic kidney disease (DKD) and DKD has been proposed to account for the majority of CVD risk observed in people with diabetes